Pharmaceutical firm GlaxoSmithKline (GSK) has confirmed job losses at one of its UK sites. It is believed about 200 roles ...

Verona in Italy and part of its Barnard Castle plant. GSK has also scrapped an investment to build a new biopharmaceutical facility in Ulverston. As well as Horlicks and MaxiNutrition, GSK said it ...

GSK was able to avert industrial action at ... with additional actions planned for Irvine, Ware, Barnard Castle, Worthing and Ulverston over the remainder of the month. All told, it is estimated ...

GSK opens Barnard Castle unit In another boost to the UK biopharma sector, GSK also officially opened its £90 million new aseptic manufacturing facility at its Barnard Castle site in County ...

(Reuters) -GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued ...

The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants. The firm says staff were told about the potential job losses and site's closure on Monday.

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the May 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time ...

Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...